Get the Stockscreener App
0.4061
13.37%
0.0479
Pre-market:
.40
-0.0061
-1.50%
Heron Therapeutics Inc Stock (HRTX) Forecast
The Heron Therapeutics Inc (HRTX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $1.3834, representing a +240.66% increase from the current price of $0.4061. The highest analyst price target is $2.7389, and the lowest is $0.0279.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month HRTX Price Target
Average 3.0019
(+639.21% Upside)
Is Heron Therapeutics Inc (HRTX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 62.64 | Neutral |
| STOCH(9,6) | 68.87 | Neutral |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | 0.0101 | Buy |
| ADX(14) | 25.24 | Buy |
| William %R | -2.8179 | Sell |
| CCI(14) | 121.36 | Buy |
Buy: 3
Sell: 2
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.3465
Buy
|
0.354
Buy
|
| MA20 |
0.3241
Buy
|
0.3398
Buy
|
| MA50 |
0.3457
Buy
|
0.3649
Buy
|
| MA100 |
0.4307
Sell
|
0.4778
Sell
|
| MA200 |
0.775
Sell
|
0.7226
Sell
|
Buy: 6
Sell: 4
Neutral: 0
Summary: Buy
According to our latest analysis, HRTX could be considered a Strong Buy, with 17 technical analysis indicators signaling 9 Buy signals, 6 signaling Sell signals and 2 Neutral signals. This might be a good time to open fresh positions on HRTX, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 62.64 indicates that HRTX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 68.87 indicates that HRTX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that HRTX is oversold. This suggests that HRTX price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 25.24 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 121.36 indicates that HRTX is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term HRTX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Heron Therapeutics Inc financial reports and earnings history, Heron Therapeutics Inc (HRTX) stock could reach $2.6021 by 2030, $19.34 by 2040 and $41.32 by 2050. See the projected annual prices until 2050 of the Heron Therapeutics Inc stock below:
- Heron Therapeutics Inc (HRTX) is expected to reach an average price of $8.7752 in 2035, with a high prediction of $9.1958 and a low estimate of $8.9816. This indicates an $2,061% rise from the last recorded price of $0.4061.
- Heron Therapeutics Inc (HRTX) stock is projected to chart a bullish course in 2040, with an average price target of $18.81, representing an $4,533% surge from its current level. The forecast ranges from a conservative $18.93 to a sky-high $19.34.
- Our analysts predict Heron Therapeutics Inc (HRTX) to jump 6,967% by 2045, soaring from $29.11 to an average price of $28.70, potentially reaching $29.00. While $29.11 is the low estimate, the potential upside is significant.
- Heron Therapeutics Inc (HRTX) stock is expected to climb by 2050, reaching an average of $41.58, a $10,140% jump from its current level. However, a wide range of estimates exists, with high and low targets of $41.32 and $41.21, respectively, highlighting the market's uncertainty.
Heron Therapeutics Inc Stock (HRTX) Year by Year Forecast
Heron Therapeutics Inc Stock (HRTX) Price Forecast for 2026
The predicted value for Heron Therapeutics Inc (HRTX) in 2026 is set at an average of $1.3834. Estimates vary from a peak of $2.7389 to a trough of $0.0279, indicating an +240.66% surge from the present price of $0.4061.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $0.5015 | $0.0279 | $2.7389 | +23.50% |
| December, 2026 | $0.3613 | $0.4887 | $0.4813 | -11.04% |
Heron Therapeutics Inc Stock (HRTX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Heron Therapeutics Inc (HRTX) is $3.4983, with a high forecast of $5.976 and a low forecast of $1.0205. This indicates an +761.43% increase from the last price of $0.4061.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1.3059 | $1.0205 | $0.7091 | +221.58% |
| February, 2027 | $0.7831 | $1.1031 | $0.7995 | +92.84% |
| March, 2027 | $4.4272 | $2.1399 | $3.7572 | +990.16% |
| April, 2027 | $3.2044 | $3.5344 | $3.6008 | +689.06% |
| May, 2027 | $4.9784 | $3.4912 | $4.1884 | +1,126% |
| June, 2027 | $5.6556 | $5.642 | $5.4956 | +1,293% |
| July, 2027 | $5.4228 | $6.0124 | $5.976 | +1,235% |
| August, 2027 | $5.9268 | $5.88 | $5.9464 | +1,359% |
| September, 2027 | $3.734 | $3.744 | $5.7236 | +819.48% |
| October, 2027 | $3.3312 | $4.2008 | $4.0744 | +720.29% |
| November, 2027 | $4.5552 | $4.1484 | $4.0252 | +1,022% |
| December, 2027 | $4.7324 | $4.3306 | $4.1706 | +1,065% |
Heron Therapeutics Inc Stock (HRTX) Price Forecast for 2028
In 2028, Heron Therapeutics Inc (HRTX) is projected to reach an average price of $5.2259, with a high projection of $5.7837 and a low estimate of $4.6681. This indicates an +1,187% rise from the last price of $0.4061.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $5.1664 | $5.1192 | $5.1314 | +1,172% |
| February, 2028 | $5.2937 | $5.4369 | $5.2137 | +1,204% |
| March, 2028 | $4.8709 | $4.8141 | $5.0755 | +1,099% |
| April, 2028 | $4.8281 | $4.9895 | $4.7981 | +1,089% |
| May, 2028 | $5.0421 | $5.1535 | $5.0135 | +1,142% |
| June, 2028 | $4.4993 | $5.0293 | $5.3607 | +1,008% |
| July, 2028 | $5.7633 | $4.6681 | $5.6533 | +1,319% |
| August, 2028 | $5.6905 | $5.8505 | $5.7837 | +1,301% |
| September, 2028 | $5.5977 | $5.6477 | $5.6141 | +1,278% |
| October, 2028 | $4.9717 | $5.1317 | $5.3645 | +1,124% |
| November, 2028 | $4.8589 | $4.8689 | $4.801 | +1,096% |
| December, 2028 | $5.3561 | $4.9057 | $5.1361 | +1,219% |
Heron Therapeutics Inc Stock (HRTX) Price Forecast for 2029
The 2029 price forecast for Heron Therapeutics Inc Stock (HRTX) is $3.4802 on average, with a high prediction of $5.5187 and a low estimate of $1.4418. This represents an +756.99% increase from the previous price of $0.4061.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $5.5734 | $5.369 | $5.4912 | +1,272% |
| February, 2029 | $4.9774 | $5.5237 | $5.5187 | +1,126% |
| March, 2029 | $4.4446 | $4.6436 | $4.6278 | +994.45% |
| April, 2029 | $3.6186 | $3.9986 | $4.0614 | +791.06% |
| May, 2029 | $3.2458 | $3.334 | $3.4604 | +699.26% |
| June, 2029 | $2.843 | $2.9934 | $3.0826 | +600.07% |
| July, 2029 | $2.567 | $2.5502 | $2.7798 | +532.11% |
| August, 2029 | $2.7542 | $2.6056 | $2.4838 | +578.21% |
| September, 2029 | $1.8714 | $2.3214 | $2.6211 | +360.83% |
| October, 2029 | $1.6754 | $1.4418 | $1.4532 | +312.57% |
| November, 2029 | $1.5226 | $1.5726 | $1.3708 | +274.94% |
| December, 2029 | $2.6767 | $1.7094 | $2.4667 | +559.11% |
Heron Therapeutics Inc Stock (HRTX) Price Forecast for 2030
Heron Therapeutics Inc Stock (HRTX) is expected to reach an average price of $1.8529 in 2030, with a high forecast of $2.8605 and a low forecast of $0.8454. This signifies an +356.27% surge from the last price of $0.4061.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $2.6039 | $2.6803 | $2.6021 | +541.19% |
| February, 2030 | $2.2211 | $2.3993 | $2.3307 | +446.93% |
| March, 2030 | $2.4683 | $2.5083 | $2.3565 | +507.80% |
| April, 2030 | $2.8523 | $2.4301 | $2.8605 | +602.36% |
| May, 2030 | $2.3595 | $2.4095 | $2.2795 | +481.01% |
| June, 2030 | $2.1467 | $2.2899 | $2.3163 | +428.62% |
| July, 2030 | $1.8807 | $1.9807 | $1.8935 | +363.12% |
| August, 2030 | $1.0979 | $1.1879 | $1.1075 | +170.36% |
| September, 2030 | $1.4719 | $1.2247 | $1.3119 | +262.46% |
| October, 2030 | $1.0691 | $0.9223 | $0.8987 | +163.27% |
| November, 2030 | $0.9464 | $1.1564 | $1.1496 | +133.04% |
| December, 2030 | $0.6804 | $0.8454 | $0.91 | +67.54% |
1.64%
0.29%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):